Updated Jul 16, 2026 · Last SEC filing 2026-07-01
Protara Therapeutics, Inc. (TARA) has filed 10 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-01. 3 Form 8-K material event filings were reported by TARA in the last 90 days. 3 Form 144 notices of proposed sale were filed for TARA stock. InsiderAlpha tracks every TARA SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001359931 |
|---|
| Form 4 filings (90d) | 10 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Form 144 notices (90d) | 3 |
| Latest Form 4 filing | 2026-07-01 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Shefferman Jesse | CEO and President | G — Bona-fide gift | 7.0K | $0.00 | — | SEC | |
| Shefferman Jesse | CEO and President | G — Bona-fide gift | 5.0K | $0.00 | — | SEC | |
| Shefferman Jesse | CEO and President | G — Bona-fide gift | 4.0K | $0.00 | — | SEC | |
| Shefferman Jesse | CEO and President | G — Bona-fide gift | 14.0K | $0.00 | — | SEC | |
| Shefferman Jesse | CEO and President | M — Option exercise | 215.7K | $1.91 | $412K | SEC | |
| Shefferman Jesse | CEO and President | S — Open-market sale | 215.7K | $4.09 | $882K | SEC | |
| CONKLING WILLIAM | Chief Commercial Officer | F — Tax withholding / forfeiture | 6.0K | $4.34 | $26K | SEC | |
| Zummo Jacqueline | Chief R&D Officer | S — Open-market sale [10b5-1] | 1.1K | $5.40 | $6K | SEC | |
| Zummo Jacqueline | Chief R&D Officer | S — Open-market sale [10b5-1] | 22.6K | $5.26 | $119K | SEC | |
| Fabbio Patrick | Chief Financial Officer | F — Tax withholding / forfeiture | 3.3K | $6.67 | $22K | SEC | |
| Fry Hannah | VP, Controller | F — Tax withholding / forfeiture | 1.5K | $6.67 | $10K | SEC | |
| Shefferman Jesse | CEO and President | F — Tax withholding / forfeiture | 8.7K | $6.67 | $58K | SEC | |
| Zummo Jacqueline | Chf Scientific Operations Off | F — Tax withholding / forfeiture | 3.7K | $6.67 | $25K | SEC | |
| Fabbio Patrick | Chief Financial Officer | F — Tax withholding / forfeiture | 3.1K | $5.60 | $17K | SEC | |
| Shefferman Jesse | CEO and President | F — Tax withholding / forfeiture | 16.3K | $5.60 | $91K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Protara Therapeutics, Inc. (TARA). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Shefferman Jesse | 7 | $1.29M |
| Smith Cynthia | 1 | — |
| Levy Richard S | 1 | — |
| Flannelly Barry P | 1 | — |
| BESHAR LUKE M | 1 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in TARA insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live TARA dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.